Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial
Gladys N. Pachas, Corinne Cather, Sarah I. Pratt, Bettina Hoeppner, Johanna Nino, Sara V. Carlini, Eric D. Achtyes, Harry Lando, Kim T. Mueser, Nancy A. Rigotti, Donald C. Goff, A. Eden Evins
Dive into the research topics of 'Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week open-label trial'. Together they form a unique fingerprint.